2021
DOI: 10.1101/2021.11.22.469576
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A modified porous silicon microparticle promotes mucosal delivery of SARS-CoV-2 antigen and induction of potent and durable systemic and mucosal T helper 1 skewed protective immunity

Abstract: Development of optimal SARS-CoV-2 vaccines to induce potent, long-lasting immunity and provide cross-reactive protection against emerging variants remains a high priority. Here, we report that a modified porous silicon microparticle (mPSM)-adjuvanted SARS-CoV-2 receptor-binding domain (RBD) vaccine activated dendritic cells and generated more potent and durable SARS-CoV-2-specific systemic humoral and type 1 helper T (Th) cell-mediated immune responses than alum-formulated RBD following parenteral vaccination,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 50 publications
0
2
0
Order By: Relevance
“…The intranasal vaccine stimulated both local mucosal and systemic immunity [ 242 ]. Also, a modified intranasal porous silicon microparticle (mPSM)-adjuvanted SARS-CoV-2 RBD vaccine was developed [ 243 ]. Boost vaccinations with intranasal mPSM-RBD vaccine diminished lung inflammation and viral loads following Delta variant infection [ 243 ].…”
Section: Needle-free Particulate Delivery Systems Of Covid-19 Vaccinementioning
confidence: 99%
See 1 more Smart Citation
“…The intranasal vaccine stimulated both local mucosal and systemic immunity [ 242 ]. Also, a modified intranasal porous silicon microparticle (mPSM)-adjuvanted SARS-CoV-2 RBD vaccine was developed [ 243 ]. Boost vaccinations with intranasal mPSM-RBD vaccine diminished lung inflammation and viral loads following Delta variant infection [ 243 ].…”
Section: Needle-free Particulate Delivery Systems Of Covid-19 Vaccinementioning
confidence: 99%
“…Also, a modified intranasal porous silicon microparticle (mPSM)-adjuvanted SARS-CoV-2 RBD vaccine was developed [ 243 ]. Boost vaccinations with intranasal mPSM-RBD vaccine diminished lung inflammation and viral loads following Delta variant infection [ 243 ]. It stimulated SARS-CoV-2 specific IgA responses, lung resident memory T and B cells, along with potent systemic immunity [ 243 ].…”
Section: Needle-free Particulate Delivery Systems Of Covid-19 Vaccinementioning
confidence: 99%